Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 342

1.

Trypanosoma cruzi triggers an early type I IFN response in vivo at the site of intradermal infection.

Chessler AD, Unnikrishnan M, Bei AK, Daily JP, Burleigh BA.

J Immunol. 2009 Feb 15;182(4):2288-96. doi: 10.4049/jimmunol.0800621.

3.

Increased expression and secretion of ICAM-1 during experimental infection with Trypanosoma cruzi.

Laucella S, Salcedo R, Castaños-Velez E, Riarte A, De Titto EH, Patarroyo M, Orn A, Rottenberg ME.

Parasite Immunol. 1996 May;18(5):227-39.

PMID:
9229375
4.

NK1.1+ cells and T-cell activation in euthymic and thymectomized C57Bl/6 mice during acute Trypanosoma cruzi infection.

Cardillo F, Cunha FQ, Tamashiro WM, Russo M, Garcia SB, Mengel J.

Scand J Immunol. 2002 Jan;55(1):96-104.

5.

TLR-dependent induction of IFN-beta mediates host defense against Trypanosoma cruzi.

Koga R, Hamano S, Kuwata H, Atarashi K, Ogawa M, Hisaeda H, Yamamoto M, Akira S, Himeno K, Matsumoto M, Takeda K.

J Immunol. 2006 Nov 15;177(10):7059-66.

6.

Resistance to Trypanosoma cruzi infection in mice does not necessarily correlate with production of interferon-gamma in vivo.

Meyer zum Büschenfelde C, Cramer S, Fleischer B, Frosch S.

Med Microbiol Immunol. 1998 Oct;187(2):107-13.

PMID:
9832325
7.

Immune resistance to Trypanosoma cruzi: synergy of specific antibodies and recombinant interferon gamma in vivo.

Plata F, Garcia-Pons F, Wietzerbin J.

Ann Inst Pasteur Immunol. 1987 May-Jun;138(3):397-415.

PMID:
3115278
8.

Cytokine responses in Trypanosoma cruzi-infected children in Paraguay.

Samudio M, Montenegro-James S, Cabral M, Martinez J, Rojas de Arias A, James MA.

Am J Trop Med Hyg. 1998 Jan;58(1):119-21.

PMID:
9452302
9.

Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice.

Torrico F, Heremans H, Rivera MT, Van Marck E, Billiau A, Carlier Y.

J Immunol. 1991 May 15;146(10):3626-32.

PMID:
1902858
10.

Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8.

Rottenberg ME, Riarte A, Sporrong L, Altcheh J, Petray P, Ruiz AM, Wigzell H, Orn A.

Immunol Lett. 1995 Feb;45(1-2):53-60.

PMID:
7622189
11.

Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele elicits attenuated Chagas' disease in mice.

Garzón E, Borges MC, Cordeiro-da-Silva A, Nacife V, Meirelles Mde N, Guilvard E, Bosseno MF, Guevara AG, Brenière SF, Ouaissi A.

Immunol Lett. 2003 Oct 9;89(1):67-80.

PMID:
12946866
12.

Trypanosoma cruzi-induced decrease in the level of interferon-gamma receptor expression by resting and activated human blood lymphocytes.

Kierszenbaum F, Mejia Lopez H, Tanner MK, Sztein MB.

Parasite Immunol. 1995 Apr;17(4):207-14.

PMID:
7624161
13.

NFATc1 mediates Toll-like receptor-independent innate immune responses during Trypanosoma cruzi infection.

Kayama H, Koga R, Atarashi K, Okuyama M, Kimura T, Mak TW, Uematsu S, Akira S, Takayanagi H, Honda K, Yamamoto M, Takeda K.

PLoS Pathog. 2009 Jul;5(7):e1000514. doi: 10.1371/journal.ppat.1000514. Epub 2009 Jul 17.

14.
15.

Impairment in natural killer cells editing of immature dendritic cells by infection with a virulent Trypanosoma cruzi population.

Batalla EI, Pino Martínez AM, Poncini CV, Duffy T, Schijman AG, González Cappa SM, Alba Soto CD.

J Innate Immun. 2013;5(5):494-504. doi: 10.1159/000350242. Epub 2013 May 8.

PMID:
23689360
16.

Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice.

Bhatia V, Garg NJ.

Clin Vaccine Immunol. 2008 Aug;15(8):1158-64. doi: 10.1128/CVI.00144-08. Epub 2008 Jun 11.

17.

CTLA-4 blockage increases resistance to infection with the intracellular protozoan Trypanosoma cruzi.

Martins GA, Tadokoro CE, Silva RB, Silva JS, Rizzo LV.

J Immunol. 2004 Apr 15;172(8):4893-901.

18.

CTLA-4 regulates the murine immune response to Trypanosoma cruzi infection.

Graefe SE, Jacobs T, Wächter U, Bröker BM, Fleischer B.

Parasite Immunol. 2004 Jan;26(1):19-28.

19.

Interaction of natural killer cells with Trypanosoma cruzi-infected fibroblasts.

Lieke T, Steeg C, Graefe SE, Fleischer B, Jacobs T.

Clin Exp Immunol. 2006 Aug;145(2):357-64.

20.

Timing of expression of inflammatory mediators in skeletal muscles from mice acutely infected with the RA strain of Trypanosoma cruzi.

Cutrullis RA, Postan M, Petray PB, Corral RS.

Pathobiology. 2009;76(4):170-80. doi: 10.1159/000218333. Epub 2009 Jun 29.

PMID:
19571606

Supplemental Content

Support Center